Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/23/2013

Company Name Symbol %Change
WESTELL TECH WSTL
6.67%
STEIN MART I SMRT
5.38%
ALLIANCE FIB AFOP
5.21%
DAWSON GEOPH DWSN
4.33%
MARRIOTT VAC VAC
3.27%

Humana Closes SeniorBridge Purchase

by Zacks Equity Research

July 10, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Humana Inc. ( HUM - Analyst Report ) has completed the acquisition of chronic-care provider SeniorBridge for an undisclosed amount. The purchase deal was announced in November last year.

New York-based SeniorBridge is a healthcare provider, which offers in-home care to seniors with chronic diseases such as Alzheimer’s disease, Parkinson’s disease and congestive heart failure. It has a network of 1,500 care managers in the U.S.

The above-mentioned deal is not likely to have any material impact on Humana’s 2012 earnings. With revenues of $72 million in 2011, SeniorBridge is substantially smaller than Humana, which recorded total revenue of $36.83 billion for the same period.

The acquisition will expand Humana’s Health and Well Being segment, which provides primary care, pharmacy, integrated wellness, and home care services. While SeniorBridge currently concentrates on providing care to private-pay customers, the in-home care service will complement the Humana Cares division of the group company, which offers care management services to 185,000 chronically ill people.

SeniorBridge’s services will be particularly useful for Humana’s Medicare members as professional post-hospitalization home care will significantly reduce readmissions and will also ensure speedy recovery. Moreover, professional care at home will improve the general health of the old and chronically-ill members of Humana.

The demand for in-home care is bound to grow with the increasing age of the baby boomer population. The populace eligible for Medicare is expected to increase to 55 million by 2020 and 72 million by 2030 from 40 million in 2011.

Humana Inc. is one of the largest health care plan providers in the U.S. and competes with companies like WellPoint Inc. ( WLP - Analyst Report ) and Aetna Inc. ( AET - Analyst Report ) . The company has been on an acquisition spree since mid-2011 and is rapidly expanding its business with special focus on the expansion of its Medicare business.

Humana completed the acquisition of Arcadian Management Services, a Medicare Advantage health maintenance organization, in April 2012. Earlier, in January 2012, the company announced the completion of its acquisition of California-based MD Care, a three-year old privately-held Medicare Advantage health maintenance organization.

Currently, the company carries a Zacks #3 Rank, implying a short-term ‘Hold’ rating. We maintain a long-term ‘Neutral’ recommendation on the stock.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.